Development of ischemic colitis and scleroderma renal crisis following methylprednisolone pulse therapy for progressive systemic sclerosis

Internal Medicine

Volumn 35, Issue 7, 1996, Pages 583-586

  Yamanishi, Yuji ^a   Yamana, Seizo ^b   Ishioka, Shinichi ^a   Yamakido, Michio ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b Hiroshima Memorial Hospital   (Japan)

Author keywords

interstitial pneumonia; pathogenesis; renal failure; side effect; steroid pulse therapy

Indexed keywords

METHYLPREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; ISCHEMIC COLITIS; KIDNEY DISEASE; SCLERODERMA; SYSTEMIC SCLEROSIS;

EID: 0029743142     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.35.583     Document Type: Article

References (15)

1. Williams IA, Baylis EM, Shipley ME. A double-blind placebo-controlled trial of methylprednisolone pulse therapy in active rheumatoid disease. Lancet 2: 237, 1982.
2. Clarke AG, Salaman JR. Methyl prednisolone in the treatment of renal transplant rejection. Clin Nephrol 2: 230, 1974.
3. Mussche MM, Ringoir SMG, Lameire NN. High intravenous doses of methylprednisolone for acute cadaveric renal allograft rejection. Nephron 16: 287, 1976.
4. Stubbs SS, Morrell RM. Intravenous methylprednisolone sodium succinate: adverse reactions reported in association with immunosuppressive therapy. Transplant Proc 5: 1145, 1973.
5. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (Scleroderma). Arthritis Rheum 23: 581, 1980.
6. D'Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (Scleroderma): a study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 46: 428, 1969.
7. Williams LF Jr, Wittenberg J. Ischemic colitis: an useful clinical diagnosis, but is it ischemic? Ann Surg 182: 439, 1975.
8. Matolo NM, Albo D Jr. Gastrointestinal complications of collagen vascular diseases: surgical implications. Am J Surg 122: 678, 1971.
9. Reeders JWAJ, Tytgat GNJ, Rosenbusch G, Gratama S. Ischemic Colitis. Martinus Nijhoff, Boston, 1984, p.17.
10. Toth A, Alpert LI. Progressive systemic sclerosis terminating as periarteritis nodosa. Arch Pathol 92: 31, 1971.
11. Traub YM, Shapiro AP, Rodnan GP, et al. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis: review of a 25 year experience with 68 cases. Medicine (Baltimore) 62: 335, 1983.
12. Steen VD, Medsger TA Jr, Osial TA Jr, Ziegler GL, Shapiro AP, Rodnan GP. Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med 76: 779, 1984.
13. Urai L, Nagy Z, Szinay G, Wiltner W. Renal function in scleroderma. Br Med J 2: 1264, 1958.
14. Cannon PJ, Hassar M, Case DB, Casarella WJ, Sommers SC, LeRoy EC. The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation. Medicine (Baltimore) 53: 1, 1974.
15. Rodnan GP, Schreiner GE, Black RL. Renal involvement in progressive systemic sclerosis (generalized scleroderma). Am J Med 23: 445, 1957.